Dedicated solely to molecular diagnostics, DiagCor was established in 2006. The global leader in
flow-through hybridization technology, we offer a range of products, solutions and services related to RNA and DNA analysis.
Hybridization is an essential step in medium resolution DNA and RNA analysis. DiagCor’s flexible flow-through hybridization platform simplifies lab workflow and reduces overheads.
We have developed our core technology into a range of molecular and cytogenetic services. Our products and services spans prenatal diagnosis, genetic testing, parentage investigation, cancer testing and infectious disease identification.
Our research and development pipeline includes tests in other areas such as cancer biomarker identification and pharmacogenomics.
DiagCor offers a complete platform for commercial and clinical MDx diagnosis.
We have helped to establish high-capability MDx labs all around the world. We serve clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Our customers enjoy extensive support from our team of dedicated MDx specialists.
Our partnerships with research institutions and MDx practitioners help to keep us on the forefront of practical bioscience.
Molecular diagnosis has recently been described as the fastest growing segment of the in vitro diagnostics (IVD) industry. DiagCor translates cutting-edge MDx research into practical, proven market applications.
We are vertically equipped to manage the entire MDx development process. Our operations span primary research, clinical and market studies, to manufacturing, commercialization, global distribution and ongoing support.
Global demand for MDx products and services is growing fast. Factors driving this growth include:
DiagCor is structured to innovate in MDx and encourages close cooperation between our R&D and production, commercial laboratory and marketing teams.
We stay at the forefront of developments in bioscience by continually investing in systems, technology and talent.
By combining R&D know-how with practical commercial lab experience we can quickly develop proven products with strong market potential.
DiagCor is led, guided and operated by a respected group of biotech scientists and executives with an extraordinary depth and breadth of experience.
The combined talents of our team enable our company to stay on the forefront of developments in MDx innovations. Qualified and experienced individuals in the life science sector are invited to inquire about working with DiagCor.
DiagCor MDx services and solutions are available worldwide via our rapidly expanding network of partners and distributors. We also offer fast support from our Hong Kong headquarters.
DiagCor works with commercial, institutional and governmental organizations across the world to bring MDx understanding and benefits to as many people as possible.
Chinese University of Hong Kong
City University of Hong Kong
Mammalian species identification in food with flow-through hybridization
University of Hong Kong
HPV screening in an Asian population
Hong Kong Society of Molecular Diagnostic Sciences
Independent evaluation of tuberculosis diagnostic kit
We work with the following commercial organizations and encourage bioscience executives across the world to contact us to discuss how we might collaborate.
We work with the following NGOs as part of our initiatives to provide people with better healthcare.